BNP Paribas Financial Markets
FRTX

BNP Paribas Financial Markets’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Hold
0
– -$1.16K – 3885
2013
Q4 		– Sell
-7
Closed -$26.5K – 3820
2013
Q3 		$26.2K Sell
7
-2
-22% -$15K ﹤0.01% 2556
2013
Q2 		$84.4K Buy
+9
New +$99.7K ﹤0.01% 2575

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

BNP Paribas Financial Markets's FRTX Position: Q1 2014 in Review

BNP Paribas Financial Markets held its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) position steady in Q1 2014 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3885.

BNP Paribas Financial Markets first reported a position in FRTX in Q2 2013 and has held it in 2 quarters since. The position peaked at $84.4K in Q2 2013. 78 funds tracked by Wall St. Rank hold FRTX as of Q1 2014.

  • BNP Paribas Financial Markets held 0 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $0 as of Q1 2014.
  • BNP Paribas Financial Markets left its Fresh Tracks Therapeutics, Inc. Common Stock share count unchanged in Q1 2014.
  • Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2014, its #3885 holding.
  • BNP Paribas Financial Markets first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 2 quarters since.
  • BNP Paribas Financial Markets's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $84.4K in Q2 2013.
  • 78 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2014, filed 13 May 2014.